ELAN PHARMA INTERNATIONAL LIMITED
Patent Owner
Stats
- 24 US PATENTS IN FORCE
- 1 US APPLICATIONS PENDING
- Jul 11, 2017 most recent publication
Details
- 24 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 14,833 Total Citation Count
- Nov 18, 1986 Earliest Filing
- 172 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9701746 Methods of treating neuropathic pain with specific binding members for NGFApr 18, 16Jul 11, 17[A61K, C07K]
6843782 Pre-filled drug-delivery device and method of manufacture and assembly of sameApr 18, 01Jan 18, 05[A61M]
6824529 Pre-filled drug-delivery device and method of manufacture and assembly of sameApr 17, 01Nov 30, 04[A61M]
6585707 Drug delivery device having improved adhesion and attachment system for drug delivery deviceMay 20, 99Jul 01, 03[A61F]
6520941 Method and device for entrapping gas within a liquid drug containerOct 12, 99Feb 18, 03[B65D, A61M]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2013/0172,279 COMPOSITION FOR TOPICAL TREATMENT OF MIXED VAGINAL INFECTIONSAbandonedJul 25, 12Jul 04, 13[A61K]
2012/0128,780 NANOPARTICULATE BISPHOSPHONATE COMPOSITIONSAbandonedOct 17, 11May 24, 12[A61K, B82Y, A61P]
2012/0087,984 STABILIZATION OF CHEMICAL COMPOUNDS USING NANOPARTICULATE FORMULATIONSAbandonedOct 03, 11Apr 12, 12[A61K, B82Y, C07D, A61P]
2012/0003,319 COMPOSITIONS FOR SITE-SPECIFIC DELIVERY OF IMATINIB AND METHODS OF USEAbandonedMar 19, 09Jan 05, 12[A61K]
8017348 Assay for Parkinson's Disease therapeuticsExpiredJul 21, 08Sep 13, 11[C12Q, C12N, G01N, C40B]
2011/0182,893 PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASESAbandonedFeb 23, 11Jul 28, 11[A61K, A61P]
2011/0177,066 PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASESAbandonedFeb 23, 11Jul 21, 11[A61K, A61P]
2011/0159,054 NANOPARTICULATE BICALUTAMIDE FORMULATIONSAbandonedMar 02, 11Jun 30, 11[A61K, B82Y, C07C, A61P]
2011/0064,800 NANOPARTICULATE AND CONTROLLED RELEASE COMPOSITIONS COMPRISING CYCLOSPORINEAbandonedSep 23, 10Mar 17, 11[A61K, B82Y, A61P]
2011/0064,803 NANOPARTICULATE AND CONTROLLED RELEASE COMPOSITIONS COMPRISING VITAMIN K2AbandonedMay 09, 06Mar 17, 11[A61K, A61P]
2011/0027,371 Nanoparticulate statin formulations and novel statin combinationsAbandonedMar 06, 06Feb 03, 11[A61K, A61P]
2011/0008,435 Nanoparticulate and Controlled Release Compositions Comprising Aryl-Heterocyclic CompoundsAbandonedFeb 07, 07Jan 13, 11[A61K, A61P]
2010/0329,976 NANOPARTICULATE COMPOSITIONS OF ANGIOGENESIS INHIBITORSAbandonedAug 27, 10Dec 30, 10[A61K]
2010/0322,852 NANOPARTICULATE COMPOSITIONS OF ANGIOGENESIS INHIBITORSAbandonedAug 27, 10Dec 23, 10[A61K, A61P]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
